Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
2.730
-0.010 (-0.36%)
At close: Apr 28, 2026, 4:00 PM EDT
2.750
+0.020 (0.73%)
After-hours: Apr 28, 2026, 7:56 PM EDT
Exagen Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Exagen stock have an average target of 8.86, with a low estimate of 7.00 and a high estimate of 10. The average target predicts an increase of 224.54% from the current stock price of 2.73.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Exagen stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +193.04% | Apr 20, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $15 → $10 | Strong Buy | Maintains | $15 → $10 | +266.30% | Mar 11, 2026 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $12 → $10 | Strong Buy | Maintains | $12 → $10 | +266.30% | Mar 11, 2026 |
| Keybanc | Keybanc | Buy Maintains $15 → $10 | Buy | Maintains | $15 → $10 | +266.30% | Mar 11, 2026 |
| BTIG | BTIG | Strong Buy Maintains $10 → $9 | Strong Buy | Maintains | $10 → $9 | +229.67% | Mar 10, 2026 |
Financial Forecast
Revenue This Year
71.98M
from 66.58M
Increased by 8.12%
Revenue Next Year
81.34M
from 71.98M
Increased by 13.00%
EPS This Year
-0.75
from -0.93
EPS Next Year
-0.47
from -0.75
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 75.1M | 88.8M | |||||
| Avg | 72.0M | 81.3M | |||||
| Low | 69.1M | 76.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 12.8% | 23.4% | |||||
| Avg | 8.1% | 13.0% | |||||
| Low | 3.7% | 6.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.75 | -0.42 | |
| Avg | -0.75 | -0.47 | |
| Low | -0.78 | -0.53 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.